**Core Concept**
Islet cell transplantation is a treatment for type 1 diabetes mellitus, which involves transplanting isolated islet cells from a donor pancreas into the recipient's liver. This procedure aims to restore insulin production and alleviate the symptoms of diabetes.

**Why the Correct Answer is Right**
The liver is the preferred site for islet cell transplantation due to its rich blood supply, which allows for optimal engraftment and function of the transplanted islets. The portal vein, a branch of the hepatic artery, supplies oxygen and nutrients to the transplanted islets, promoting their survival and insulin production. The liver's immune-privileged status also reduces the risk of rejection.

**Why Each Wrong Option is Incorrect**
**Option A:** The spleen is not a suitable site for islet cell transplantation due to its limited blood supply and high risk of splenic infarction. Additionally, the spleen's immune function may interfere with the transplanted islets.
**Option B:** The kidney is not an ideal site for islet cell transplantation due to its limited surface area and potential for immune rejection.
**Option C:** The pancreas is the organ of origin for islet cells, but transplanting islets into the pancreas itself is not a viable option due to the risk of graft-versus-host disease and the limited availability of donor pancreata.

**Clinical Pearl / High-Yield Fact**
The Edmonton protocol, a standardized islet isolation and transplantation technique, has significantly improved the outcomes of islet cell transplantation, leading to improved glycemic control and reduced hypoglycemia in patients with type 1 diabetes.

**Correct Answer:**
**Correct Answer:** C.